Enlitic, Inc. (ASX:ENL)

Market Cap	15.75M
Revenue (ttm)	1.94M
Net Income (ttm)	-24.62M
Shares Out	583.17M
EPS (ttm)	-0.13
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	230,193
Average Volume	281,012
Open	0.0300
Previous Close	0.0270
Day's Range	0.0300 - 0.0310
52-Week Range	0.0230 - 0.1750
Beta	n/a
RSI	41.74
Earnings Date	May 29, 2025

About Enlitic

Enlitic, Inc. operates in the healthcare sector in the United States, Europe, and Japan. The company uses artificial intelligence (AI) to develop software products that manage medical imaging data in radiology, such as magnetic resonance imaging, computed tomography scans, and ultrasound images, as well as licenses its products to healthcare providers and original equipment manufacturers. Its healthcare data solutions include ENDEX, a platform that uses artificial intelligence to standardize medical imaging data; ENCOG, an AI enabled data anony...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2014
• Country: United States
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: ENL

Financial Performance

In 2024, Enlitic's revenue was $1.20 million, an increase of 115.54% compared to the previous year's $557,677. Losses were -$15.24 million, -2.02% less than in 2023.

Financial numbers in USD